The President has announced a policy of imposing a 100% tariff on certain brand-name medications. This measure will affect pharmaceutical manufacturers and consumers alike. The White House stated the action is intended to address concerns regarding supply chain vulnerabilities and rising drug prices. The tariffs are expected to impact the availability and cost of these medications for individuals relying on them. Regulatory agencies are currently assessing the potential consequences of this policy.
Credits: NYT > Top Stories
